Destiny
Pharma is an England-based biotechnology company that researches and develops novel anti-infective therapies for the treatment of infectious diseases... Read moreDestiny
Pharma is an England-based biotechnology company that researches and develops novel anti-infective therapies for the treatment of infectious diseases... Read more
News
Aug 20, 2024
FinanzNachrichten
Destiny: JP Jenkins Ltd: Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula
Aug 08, 2024
Pharmabiz
Destiny: Destiny Pharma to present data on its lead drug, Exeporfinium chloride at IPS Society conference on Sept 2325, 2024 in Birmingham
Aug 05, 2024
Sharecast
Destiny: Destiny Pharma reports positive findings from XF-73 study
Aug 05, 2024
MarketScreener
Destiny: Destiny Pharma shares fall amid XF-73 fending off MRSA in wounds
Jul 15, 2024
MarketScreener
Destiny: AIM WINNERS & LOSERS: Destiny Pharma falls on plans to go private
Jun 18, 2024
MarketScreener
Destiny: Destiny Pharma presents "exciting" data for ringworm drug
Jun 13, 2024
MarketScreener
Destiny: Destiny Pharma : Result of 2024 Annual General Meeting
Jun 11, 2024
MarketScreener
Destiny: EARNINGS AND TRADING: Chariot loss narrows; Destiny Pharma approval
May 09, 2024
MarketScreener
Destiny: Destiny Pharma : Notice of 2024 Annual General Meeting
Apr 25, 2024
Proactive Investors
Destiny: Destiny Pharma assessing options for XF-73 nasal
Destiny Competitors
1
2
3
4
5
6
7
8
9
10